NCT01124435

Who might be able to join this trial:

• You have been diagnosed with a returning (recurrent) cancer of the ovaries, fallopian tubes, or peritoneum of a specific type (serous carcinoma), and your cancer can be measured on scans.
• You have previously been treated with a platinum-based chemotherapy as your first treatment, and have had at least one further round of chemotherapy since your cancer came back.
• Your last platinum-based chemotherapy finished more than 6 months ago.
• You are 18 years of age or older.
• Your general health and ability to carry out daily activities falls within an acceptable range, as measured by a standard medical scale (confirm with trial site).
• Your blood counts and bone marrow are working well enough (confirm with trial site).
• Your kidneys and liver are functioning well enough (confirm with trial site).
• You are willing and able to give written consent to take part in the study.

Who may not be able to join:

• You have had an allergic reaction or sensitivity to celecoxib, aspirin, anti-inflammatory painkillers (such as ibuprofen), or sulfonamide drugs.
• You have significant other health conditions, including active heart disease, heart failure, uncontrolled bleeding, severely high blood pressure, a stomach ulcer in the past 12 months, chronic bowel inflammation, a blood clot in a vein or artery in the past 12 months, or a history of a blood clot in the lungs.
• You are currently taking other medications that could interact with the trial drugs (confirm with trial site).
• You have had surgery, chemotherapy, or radiotherapy within the last month.
• You are pregnant, could become pregnant, or are currently breastfeeding.
• You have previously been treated with a COX-2 inhibitor drug as part of cancer treatment.
• You have any psychological, social, or geographical circumstances that might make it difficult to follow the study schedule and attend follow-up appointments.

Important: Always verify eligibility with the trial site directly before applying.